For patients undergoing catheter ablation for persistent atrial fibrillation (AF), cryoballoon and radiofrequency catheters are both effective in achieving pulmonary vein isolation (PVI). And the ...

Feb. 14, 2005 — The European Commission has approved a potent hepatitis B adjuvant vaccine for use in specific high-risk groups; Japan's Ministry of Health, Labor, and Welfare has approved ...

Please provide your email address to receive an email when new articles are posted on . Four different pulmonary vein isolation techniques demonstrated similar efficacy in treating persistent AF.

New research shows that cryoablation is a safe and effective approach to close congenital patent foramen ovale (PFO, a small hole in the heart) in patients with atrial fibrillation (AF) undergoing ...

Boston Scientific is giving new meaning to the polar plunge. The medtech giant has received FDA approval for a catheter that uses extreme cold to attack the irregular mechanisms of the pulmonary vein ...

Please provide your email address to receive an email when new articles are posted on . Compared with a sham procedure, pulmonary vein isolation reduced atrial fibrillation burden at 6 months.

The clinical trial will assess the safety and effectiveness of a pulmonary vein isolation-only strategy to treat patients with persistent atrial fibrillation using the company’s Arctic Front Advance ...

PFA was noninferior to cryoablation for first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation. Tissue-selective energy delivery and short application times offer ...

The primary effectiveness outcomes are shown for both the full patient cohort (A) and separated by atrial fibrillation (AF) subtype: paroxysmal AF (B) vs persistent AF/long-standing (LS)–persistent AF ...